An overview on the isolation and analysis of circulating tumor DNA in plasma and serum

Annals of the New York Academy of Sciences

Volumn 906, Issue , 2000, Pages 8-12

  Jen, Jin ^a   Wu, Li ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MARKER;

BLOOD LEVEL; BLOOD SAMPLING; BLOOD STORAGE; CANCER; CONFERENCE PAPER; DNA DETERMINATION; HUMAN; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR;

EID: 0034057539     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06581.x     Document Type: Conference Paper

References (20)

1. 1. STROUN, M. et al. 1987. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol. 23: 707-712.
2. 2. STROUN, M. et al. 1989. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322.
3. 3. CHEN, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033-1035.
4. 4. NAWROZ, H. et al. 1996. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2: 1035-1037.
5. 5. ESTELLER, M. et al. 1999. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59(1): 67-70. [Published erratum appears in Cancer Res. 59(15): 3853.]
6. 6. CASTELLS, A. et al. 1999. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. Clin. Oncol. 7: 578-584.
7. 7. DE KOK, J.B. et al. 1997. Detection of tumour DNA in serum of colorectal cancer patients. Scand. J. Clin. Lab. Invest. 57: 601-604.
8. 8. HENRY, J.B. 1996. Clinical and Diagnosis Management by Laboratory Methods. Nineteenth edition. Saunders. Philadelphia.
9. 9. JUNG, R. et al. 1997. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques 23: 24, 26, and 28.
10. 10. GOELZ, S.E. 1985. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. Biophys. Res. Commun. 130: 118-126.
11. 11. HIBI, K. et al. 1998. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 58: 1405-1407.
12. 12. WONG, I.H. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59: 71-73.
13. 13. LO, Y.M. et al. 1999. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 59: 5452-5455.
14. 14. ZACH, O. et al. 1999. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol. 17: 2015.
15. 15. SUZUKI, K. et al. 1999. Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Int. J. Oncol. 15: 1227-1232.
16. 16. KOPRESKI, M.S. et al. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.
17. 17. POLYAK, K. et al. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20: 291-293.
18. 18. FLISS, M.S. et al. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Submitted.
19. 19. JEN, J. et al. 1994. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331: 213-221.
20. 20. STEINER, G. et al. 1997. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 3: 621-624.